I. Kotsantis

Journal Article

Phase Ib-II Study of Ramucirumab Combined with Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma (RACING)

g.-papaxoinis
•
Read more